Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

50
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
50
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

973
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
973
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined Analysis of Bulk and Single-Cell Transcriptomic Data Reveals Dormancy-Associated Genes in Colorectal Cancer.

International journal of molecular sciences·2026
Same author

Identification and Characterization of Cancer-Related Risk Metabolic Subpathways Reveal Their Functional Significance in Cancer.

International journal of molecular sciences·2026
Same author

Effects of constant and incremental modes of music volume and odor concentration on vigilance.

Frontiers in psychology·2026
Same author

Integrated Single-Cell Multi-Omics Analysis Reveals That a CD8<sup>+</sup> TPex-Monocyte Interaction Axis Coordinates Immune Infiltration in Alzheimer's Disease.

International journal of molecular sciences·2026
Same author

Charting cell-type-specific positive genetic interaction at single-cell resolution for lung adenocarcinoma.

NPJ precision oncology·2026
Same author

DNA methylation heterogeneity in complex tumor microenvironment: Quantitative methods, influencing factors, and clinical implications.

Genes & diseases·2026

Related Experiment Video

Updated: Jun 25, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

DDCM: A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm.

Manyi Xu1, Wan Li1, Jiaheng He1

  • 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150000, China.

International Journal of Molecular Sciences
|May 25, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel disease-drug correlation method (DDCM) using support-vector regression (SVR) to identify potential drugs for diseases like neoplasms and cardiovascular diseases. The method effectively predicts and validates therapeutic candidates, offering a new approach to drug repositioning.

Keywords:
drug repositioninghybrid matrixpotential therapeutic drugssupport-vector regression

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Related Experiment Videos

Last Updated: Jun 25, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • Drug repositioning accelerates drug development by identifying new uses for existing drugs.
  • Growing biological data necessitates advanced computational methods for effective drug discovery.
  • Identifying potential therapeutic drugs for complex diseases remains a significant challenge.

Purpose of the Study:

  • To propose a novel computational method, the disease-drug correlation method (DDCM), for predicting potential therapeutic drugs.
  • To integrate multi-source and multi-level biological data for enhanced drug repositioning accuracy.
  • To identify potential therapeutic drugs for neoplasms and cardiovascular diseases.

Main Methods:

  • Developed a disease-drug correlation method (DDCM) integrating diverse biological data.
  • Utilized support-vector regression (SVR) to predict disease-drug correlations.
  • Constructed a hybrid similarity matrix and employed a randomized perturbation and stepwise screening pipeline.

Main Results:

  • Successfully predicted potential therapeutic drugs for neoplasms and cardiovascular diseases.
  • Validated the therapeutic potential of predicted drugs through literature, function, drug targets, and survival-essential genes.
  • Demonstrated the method's feasibility by comparing results with classical methods and conducting co-drug analysis.

Conclusions:

  • The DDCM offers a rational and efficient approach to drug repositioning by leveraging integrated biological data.
  • The method provides a novel perspective for understanding disease-drug correlations and disease pathogenesis.
  • Validated predictions highlight the potential of DDCM in accelerating the discovery of new therapeutic agents.